MetLife Investment Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.54M | Buy |
|
|||||
|
2023
Q1 | $1.31M | Sell |
|
|||||
|
2022
Q4 | $569K | Sell |
|
|||||
|
2022
Q3 | $392K | Hold |
|
|||||
|
2022
Q2 | $474K | Hold |
|
|||||
|
2022
Q1 | $511K | Buy |
|
|||||
|
2021
Q4 | $259K | Hold |
|
|||||
|
2021
Q3 | $990K | Hold |
|
|||||
|
2021
Q2 | $1.39M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $1.37M | Hold |
|
|||||
|
2019
Q4 | $1.94M | Buy |
|
|||||
|
2019
Q3 | $732K | Hold |
|
|||||
|
2019
Q2 | $861K | Buy |
|
|||||
|
2019
Q1 | $716K | Hold |
|
|||||
|
2018
Q4 | $470K | Hold |
|
|||||
|
2018
Q3 | $685K | Buy |
|
|||||
|
2018
Q2 | $270K | Buy |
|
|||||
|
2018
Q1 | $92K | Hold |
|
|||||
|
2017
Q4 | $127K | Buy |
|